Corey McCann

Chief Executive Officer, Pear Therapeutics (United States).

Companies

Pear Therapeutics (United States)Board member Dec 7, 2021 to Feb 17, 2023¹
Pear Therapeutics (United States)Chief executive officer Dec 7, 2021 to Feb 17, 2023¹
Pear Therapeutics (United States)President Dec 7, 2021 to Feb 17, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pear Therapeutics (United States)9,197,351 shares²Jan 24, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 20, 2023Sold 34,731 shares at $1.13 of Pear Therapeutics (United States)²
Jan 14, 2023Exercised options 88,000 shares of Pear Therapeutics (United States)³
Dec 3, 2021Granted 986,517 shares of Pear Therapeutics (United States)⁴
Dec 3, 2021Granted 1,685,913 shares of Pear Therapeutics (United States)⁴
Dec 3, 2021Granted 8,157,656 shares of Pear Therapeutics (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPear Therapeutics (United States), Board member
2
SEC EDGARPear Therapeutics (United States) shares after the filing of Jan 24, 2023
3
SEC EDGARForm 4 filed Jan 18, 2023
4
SEC EDGARForm 4 filed Dec 7, 2021